Cargando…
Current status of 5α-reductase inhibitors in the management of lower urinary tract symptoms and BPH
PURPOSE: Benign prostatic hyperplasia (BPH) is a progressive disease that is commonly associated with bothersome lower urinary tract symptoms (LUTS) and might result in complications, such as acute urinary retention and BPH-related surgery. Therefore, the goals of therapy for BPH are not only to imp...
Autores principales: | Gravas, Stavros, Oelke, Matthias |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2809314/ https://www.ncbi.nlm.nih.gov/pubmed/19956956 http://dx.doi.org/10.1007/s00345-009-0493-y |
Ejemplares similares
-
New therapeutic strategies for the treatment of male lower urinary tract symptoms
por: Dimitropoulos, Konstantinos, et al.
Publicado: (2016) -
Solifenacin/tamsulosin fixed-dose combination therapy to treat lower urinary tract symptoms in patients with benign prostatic hyperplasia
por: Dimitropoulos, Konstantinos, et al.
Publicado: (2015) -
Efficacy of propiverine ER with or without α-blockers related to maximum urinary flow rate in adult men with OAB: results of a 12-week, multicenter, non-interventional study
por: Oelke, Matthias, et al.
Publicado: (2011) -
Relevance of benign prostatic hyperplasia and associated conditions for urologists, health care systems, and society
por: Oelke, Matthias, et al.
Publicado: (2010) -
The spectrum and etiologies of lower urinary tract symptoms in postmenopausal women
por: Bharti, Vishrut, et al.
Publicado: (2023)